stockrowElanco Animal Health Incorporated (ELAN) vs Teva Pharmaceutical Industries Ltd. (TEVA)
- Elanco Animal Health Incorporated ELAN 23.74 −6.20%
- Teva Pharmaceutical Industries Ltd. TEVA 41.73 −0.29%
Elanco Animal Health Incorporated and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $48.7B against $11.8B — 4.1× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Teva Pharmaceutical Industries Ltd. trades at 92.6×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 2.71%. Teva Pharmaceutical Industries Ltd. has the higher net margin (2.94% vs −3.96%) and the higher return on invested capital (4.09% vs 0.51%). Across the 20 metrics below, Elanco Animal Health Incorporated leads on 11 and Teva Pharmaceutical Industries Ltd. on 9.
Valuation
Profitability
| Metric | ELAN | TEVA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 53.51% | 53.51% |
| Operating margin | 1.61% | 7.84% | 0.00% |
| Net margin | (3.96%) | 2.94% | (2.45%) |
| Free cash flow margin | 7.55% | 7.71% | 0.00% |
| Return on equity | (2.98%) | 6.65% | (0.80%) |
| Return on assets | (1.46%) | 1.27% | (1.67%) |
| Return on invested capital | 0.51% | 4.09% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack